Plus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV

Press/Media: Press / Media

PeriodNov 19 2020

Media coverage

2

Media coverage

  • TitlePlus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV
    Media name/outletMENAFN -Press Releases (English)
    CountryJordan
    Date11/19/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Announces Positive Interim Data from ReSPECT™ Phase 1 Clinical Trial in Recurrent Glioblastoma Nasdaq:PSTV
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date11/19/20
    PersonsAndrew Brenner